Genomtec S.A. (WSE:GMT)
Poland
· Delayed Price · Currency is PLN 7.15
-0.14 (-1.92%)
Jun 2, 2025, 4:36 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 97.14 million as of June 2, 2025. Its market cap has decreased by -38.76% in one year.
Market Cap
97.14M
Enterprise Value
85.45M
Revenue
6.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
7.15
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 97.14M, a decrease of -12.13%. That is a compound annual growth rate of -3.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 97.14M | -7.25% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.14B |
| Synektik Spólka Akcyjna | 1.88B |
| Voxel | 1.71B |
| Celon Pharma | 1.18B |
| Ryvu Therapeutics | 719.04M |
| Selvita | 569.02M |
| Centrum Medyczne ENEL-MED | 565.61M |
| Bioceltix | 532.83M |